Targeting ROS to kill cisplatin resistant cells

The cisplatin resistant variants (empty peak) are shown to possess higher basal levels of ROS. Each histogram is representative of three experiments. (average P<0.03, parental vs. resistant), BJ1 is normal fibroblast cell line, Flow cytometry analysis of basal level of ROS in various lung cancer cell lines detected by DCF-DA probe.